Kyowa Hakko Kirin traded at 2,722.00 this Tuesday May 17th, decreasing 44.00 or 1.59 percent since the previous trading session. Looking back, over the last four weeks, Kyowa Hakko Kirin lost 1.70 percent. Over the last 12 months, its price fell by 18.38 percent. Looking ahead, we forecast Kyowa Hakko Kirin to be priced at 2,664.23 by the end of this quarter and at 2,406.83 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
2,722.00
Daily Change
-1.59%
Yearly
-18.38%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
M3 Inc 3,792.00 -51.00 -1.33% -45.49%
Kyowa Hakko Kirin 2,722.00 -44.00 -1.59% -18.38%
Takeda 3,690.00 29.00 0.79% -2.07%
Astellas Pharma 1,951.00 -5.00 -0.26% 15.55%
Sumitomo Dainippon 1,121.00 9.00 0.81% -44.72%
Shionogi 6,969.00 122.00 1.78% 20.76%
Chugai Pharma 3,554.00 -12.00 -0.34% -12.85%
Eisai 5,591.00 9.00 0.16% -18.77%
Terumo 4,036.00 56.00 1.41% 2.54%
Daiichi Sankyo 3,365.00 24.00 0.72% 27.80%
Otsuka Holdings 4,422.00 0 0% 0.16%

Indexes Price Day Year
JP225 26660 112.70 0.42% -6.15%

Kyowa Hakko Kirin
Kyowa Kirin Co., Ltd., formerly Kyowa Hakko Kirin Co., Ltd. is a Japan-based company principally engaged in the manufacture and sale of medical drugs. The Company operates through two business segments. Pharmaceuticals segment conducts research, development, manufacture and sale of pharmaceuticals and other products. Bio-chemicals segment is involved in the research, development, manufacture and sale of pharmaceuticals and industrial raw materials mainly for amino acid and nucleic acid related substances, as well as healthcare products.